Supports Brain Health: Elcafort Plus Syrup contains L-carnosine, which plays a role in supporting the structure and functions of the healthy brain in children
Oral GLP-1 Formulations and Future Projections Several companies are developing oral GLP-1 formulations, including Novo Nordisk, Pfizer, and smaller firms, positioning them as potential acquisition targets
However, this is not an oral medication
There are two types of carnitine deficiency: Primary carnitine deficiency A genetic disorder Usually develops by five years of age Symptoms include Disease of the heart muscle (cardiomyopathy) Skeletal-muscle weakness Low blood sugar (hypoglycemia) Secondary carnitine deficiency Caused by other underlying conditions that decrease the amount of carnitine in the body that cause the body to: Increase the amount of carnitine excreted in urine Absorb less carnitine from food Chronic renal failure Use of certain antibiotics Certain medicines, such as valproate Liver disease Digestive disease that causes poor absorption Malnutrition Mitochondrial disease Certain metabolic disorders From Diet and Weight Loss Resources Image source: iStock Images
Overexpression of MDM2 results in decreased level and activity of p53 (Kubbutat et al, 1997) and provides an alternative to a p53 mutation in the sense that it inactivates p53